Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 164,679 | 198,670 | 142,047 | 171,192 | 190,698 |
| Marketable Securities | 390,283 | 354,245 | 359,323 | 312,392 | 285,600 |
| Receivables | 152,622 | 154,735 | 150,624 | 111,324 | 96,314 |
| Inventories | 197,159 | 177,538 | 162,213 | 149,876 | 163,718 |
| Other current assets | 78,913 | 82,026 | 83,615 | 78,707 | 70,410 |
| TOTAL | $983,656 | $967,214 | $897,822 | $823,491 | $806,740 |
| Non-Current Assets | |||||
| PPE Net | 784,822 | 789,419 | 789,037 | 864,447 | 857,943 |
| Investments And Advances | 73,950 | 75,160 | 78,760 | 79,470 | 85,610 |
| Other Non-Current Assets | 318,590 | 327,860 | 343,270 | 374,930 | 352,480 |
| TOTAL | $1,177,362 | $1,192,439 | $1,211,067 | $1,318,847 | $1,296,033 |
| Total Assets | $1,600,270 | $1,602,123 | $1,558,978 | $1,525,919 | $1,501,416 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70,260 | 65,920 | 72,650 | 57,500 | 44,530 |
| Accrued Expenses | 117,560 | 98,710 | 88,150 | 81,330 | 80,350 |
| Other current liabilities | 16,670 | 13,810 | 9,090 | 6,300 | 13,260 |
| TOTAL | $224,423 | $187,566 | $171,494 | $153,662 | $154,327 |
| Non-Current Liabilities | |||||
| Long Term Debt | 98,329 | 106,227 | 114,147 | 117,431 | 111,221 |
| Other Non-Current Liabilities | 93,170 | 91,530 | 93,560 | 100,600 | 78,190 |
| TOTAL | $191,499 | $197,757 | $207,707 | $218,031 | $189,411 |
| Total Liabilities | $415,926 | $385,326 | $379,201 | $371,697 | $343,743 |
| Shareholders' Equity | |||||
| Common Shares | 1,141,810 | 1,182,460 | 1,179,220 | 1,179,950 | 1,179,870 |
| Retained earnings | 49,485 | 39,811 | 5,226 | -21,827 | -13,557 |
| Other shareholders' equity | -6,951 | -5,474 | -4,669 | -3,901 | -8,640 |
| TOTAL | $1,184,344 | $1,216,797 | $1,179,777 | $1,154,222 | $1,157,673 |
| Total Liabilities And Equity | $1,600,270 | $1,602,123 | $1,558,978 | $1,525,919 | $1,501,416 |